Dr. Victoria Hampshire founds CPSRC as exclusive metropolitan area preclinical animal consulting firm

After nearly three decades of public service, FDA veterinarian Victoria Hampshire has joined the private sector founding a preclinical review and consulting service Capital Preclinical Scientific Research Consultants, LLC (CPSRC, llc).  Dr. Hampshire departs her post of the last decade the FDA/CDRH Division of Cardiovascular Devices where she developed animal study guidance and procedures and also served in a lead review capacity for the Peripheral Vascular Devices Branch.  She formerly led adverse event monitoring activities at FDA’s Center for Veterinary Medicine and led NIH’s comparative animal biomedical animal research facility and 24-hour animal intensive care efforts.  Dr. Hampshire’s company will focus on assisting other consulting firms, legal entities, CROs, and animal programs with the regulatory strategy, design, preparation, conduct, and review of the preclinical submission.